| Primary |
| Hyperparathyroidism Secondary |
49.3% |
| Hypertension |
9.9% |
| Product Used For Unknown Indication |
7.2% |
| Hyperparathyroidism Primary |
4.8% |
| Hyperphosphataemia |
4.3% |
| Hyperparathyroidism |
3.7% |
| Anaemia |
2.5% |
| Nephrogenic Anaemia |
2.5% |
| Pain |
2.2% |
| Dialysis |
1.5% |
| Diarrhoea |
1.5% |
| Gastritis |
1.4% |
| Constipation |
1.3% |
| Gastric Ulcer |
1.3% |
| Insomnia |
1.3% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Renal Failure Chronic |
1.1% |
| Asthma |
1.0% |
| Depression |
1.0% |
| Pancreatic Insufficiency |
1.0% |
|
| Death |
9.2% |
| Hypercalcaemia |
9.2% |
| Cardiovascular Disorder |
7.0% |
| Convulsion |
6.3% |
| Nausea |
6.3% |
| Syncope |
5.6% |
| Abdominal Pain |
4.9% |
| Diarrhoea |
4.9% |
| Drug Ineffective |
4.9% |
| Hyperparathyroidism Secondary |
4.2% |
| Hypocalcaemia |
4.2% |
| Pleural Effusion |
4.2% |
| Vomiting |
4.2% |
| Cardiac Failure |
3.5% |
| Dyspnoea |
3.5% |
| Haemoglobin Decreased |
3.5% |
| Hypotension |
3.5% |
| Liver Disorder |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Septic Shock |
3.5% |
|
| Secondary |
| Hyperparathyroidism Secondary |
22.1% |
| Hypertension |
17.9% |
| Product Used For Unknown Indication |
12.9% |
| Hyperphosphataemia |
11.9% |
| Nephrogenic Anaemia |
6.0% |
| Dialysis |
3.8% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Hyperparathyroidism Primary |
2.5% |
| Carnitine Deficiency |
2.3% |
| Blood Parathyroid Hormone Increased |
2.2% |
| Constipation |
2.0% |
| Gastritis |
2.0% |
| Gastric Ulcer |
1.9% |
| Oliguria |
1.8% |
| Hyperparathyroidism |
1.6% |
| Insomnia |
1.6% |
| Hypocalcaemia |
1.5% |
| Delirium |
1.2% |
| Ileus |
1.2% |
| Renal Failure |
1.0% |
|
| Diarrhoea |
10.4% |
| Hyponatraemia |
8.7% |
| Liver Disorder |
8.7% |
| Malaise |
8.7% |
| Hypercalcaemia |
7.8% |
| Ventricular Tachycardia |
7.0% |
| Vomiting |
5.2% |
| Hyperphosphataemia |
4.3% |
| Hypokalaemia |
4.3% |
| Inappropriate Antidiuretic Hormone Secretion |
4.3% |
| Drug Ineffective |
3.5% |
| Hallucination, Auditory |
3.5% |
| Hypoglycaemia |
3.5% |
| Hypovolaemia |
3.5% |
| Nausea |
3.5% |
| Abdominal Discomfort |
2.6% |
| Abdominal Pain |
2.6% |
| Electrocardiogram Qt Prolonged |
2.6% |
| Leukocytoclastic Vasculitis |
2.6% |
| Nephrocalcinosis |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
60.4% |
| Hyperphosphataemia |
8.4% |
| Drug Use For Unknown Indication |
7.4% |
| Hyperparathyroidism Secondary |
5.8% |
| Hypertension |
3.6% |
| Nephrogenic Anaemia |
2.0% |
| Prophylaxis |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| Hyperparathyroidism |
1.3% |
| Pain |
1.2% |
| Renal Transplant |
1.1% |
| Constipation |
0.9% |
| Dialysis |
0.8% |
| Renal Failure |
0.8% |
| Insomnia |
0.7% |
| Nuclear Magnetic Resonance Imaging |
0.7% |
| Anaemia |
0.6% |
| Renal Failure Chronic |
0.6% |
| Glomerulonephritis Chronic |
0.5% |
| Angina Pectoris |
0.5% |
|
| Anaemia |
9.0% |
| Nausea |
7.5% |
| Hyperparathyroidism Secondary |
6.8% |
| Peritonitis |
6.0% |
| Pneumonia |
6.0% |
| Tooth Disorder |
6.0% |
| Tremor |
6.0% |
| Constipation |
4.5% |
| Haematemesis |
4.5% |
| Large Intestine Perforation |
4.5% |
| Meningitis Enterococcal |
4.5% |
| Respiratory Failure |
4.5% |
| Therapeutic Response Decreased |
4.5% |
| Blood Pressure Decreased |
3.8% |
| Neutropenia |
3.8% |
| Pancytopenia |
3.8% |
| Urinary Tract Infection |
3.8% |
| Vomiting |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Acute Myocardial Infarction |
3.0% |
|
| Interacting |
| Hypertension |
17.4% |
| Hyperparathyroidism Secondary |
10.9% |
| Pain |
10.9% |
| Dyslipidaemia |
8.7% |
| Osteoporosis |
8.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
8.7% |
| Restless Legs Syndrome |
8.7% |
| Type 2 Diabetes Mellitus |
8.7% |
| Coronary Artery Disease |
4.3% |
| Secondary Hyperthyroidism |
4.3% |
| Hyperparathyroidism |
2.2% |
| Nausea |
2.2% |
| Renal Failure |
2.2% |
| Vitamin Supplementation |
2.2% |
|
| Proteinuria |
50.0% |
| Transaminases Increased |
50.0% |
|
